tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PRRUF Stock Latest News

Immutep Ltd Updates Business Strategy at AGM 2025
Company AnnouncementsImmutep Ltd Updates Business Strategy at AGM 2025
3d ago
Immutep announces data from EFTISARC-NEO trial
PremiumThe Fly
Immutep announces data from EFTISARC-NEO trial
17d ago
IMMP
Immutep’s EFTISARC-NEO Trial Shows Promising Results in Soft Tissue Sarcoma
PremiumCompany Announcements
Immutep’s EFTISARC-NEO Trial Shows Promising Results in Soft Tissue Sarcoma
18d ago
Immutep receives EUR 2,588,954 R&D tax incentive from French Government
PremiumThe Fly
Immutep receives EUR 2,588,954 R&D tax incentive from French Government
27d ago
IMMP
Immutep Secures A$4.6 Million R&D Tax Incentive from French Government
PremiumCompany Announcements
Immutep Secures A$4.6 Million R&D Tax Incentive from French Government
28d ago
Immutep reports Q1 cash receipts from customers A$15,000
PremiumThe FlyImmutep reports Q1 cash receipts from customers A$15,000
1M ago
IMMP
Immutep Limited Announces 2025 AGM with Key Resolutions
Premium
Company Announcements
Immutep Limited Announces 2025 AGM with Key Resolutions
1M ago
Immutep Limited Releases 2025 Corporate Governance Statement
Premium
Company Announcements
Immutep Limited Releases 2025 Corporate Governance Statement
1M ago
Immutep Ltd Releases 2025 Annual Report Highlighting Strategic Developments
PremiumCompany Announcements
Immutep Ltd Releases 2025 Annual Report Highlighting Strategic Developments
1M ago
Immutep presents two posters at ESMO on changing landscape for 1L NSCLC
PremiumThe Fly
Immutep presents two posters at ESMO on changing landscape for 1L NSCLC
1M ago
IMMP
Immutep announces Phase II study of eftilagimod alfa met primary endpoint
PremiumThe Fly
Immutep announces Phase II study of eftilagimod alfa met primary endpoint
1M ago
IMMP
Immutep’s Efti Shows Promising Results in Lung Cancer Treatment
PremiumCompany Announcements
Immutep’s Efti Shows Promising Results in Lung Cancer Treatment
1M ago
Immutep’s Efti Shows Promising Results in Soft Tissue Sarcoma Trial
PremiumCompany AnnouncementsImmutep’s Efti Shows Promising Results in Soft Tissue Sarcoma Trial
1M ago
Immutep announces completion of FDA Project Optimus requirements
Premium
The Fly
Immutep announces completion of FDA Project Optimus requirements
2M ago
IMMP
Immutep Completes FDA Project Optimus, Advances Cancer Immunotherapy
Premium
Company Announcements
Immutep Completes FDA Project Optimus, Advances Cancer Immunotherapy
2M ago
Citizens JMP healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
2M ago
TIL
CBIO
Promising Developments in Immutep’s Clinical Trials Drive Buy Rating
PremiumRatings
Promising Developments in Immutep’s Clinical Trials Drive Buy Rating
2M ago
IMMP
Immutep announces update for TACTI-004 Phase III trial
PremiumThe Fly
Immutep announces update for TACTI-004 Phase III trial
2M ago
MRK
IMMP
Immutep Achieves Key Milestone in Phase III Lung Cancer Trial
PremiumCompany Announcements
Immutep Achieves Key Milestone in Phase III Lung Cancer Trial
2M ago
Immutep Director Converts Performance Rights into Shares
PremiumCompany AnnouncementsImmutep Director Converts Performance Rights into Shares
2M ago
Immutep Ltd Announces Director’s Interest Change
Premium
Company Announcements
Immutep Ltd Announces Director’s Interest Change
2M ago
Immutep Ltd Announces Director’s Acquisition of Shares
Premium
Company Announcements
Immutep Ltd Announces Director’s Acquisition of Shares
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >